Business
Helo Corp Invites Health Researchers and Medical Professionals to Join Project CEASE, an International Field Experiment to Identify the Onset of COVID-19 Infection Using AI and Anonymised VYVO Smartwatch Data
Helo Corp Invites Health Researchers and Medical Professionals to Join Project CEASE, an International Field Experiment to Identify the Onset of COVID-19 Infection Using AI and Anonymised VYVO Smartwatch Data.
About this update from Helo Corp.
[{"type":"text","content":"SAN FRANCISCO, CA / ACCESSWIRE / May 21, 2020 / Helo Corp. (OTC PINK:HLOC) ("Helo Corp"), a leading developer of wearable devices embedded with Life Sensing TechnologyTM and dedicated to improving wellness worldwide, today invites health researchers and medical professionals to join its Project CEASE (COVID-19 Early Alert System Experiment) to help format and analyse its anonymised VYVO smartwatch wearer data to see if data patterns gathered from its wellness devices can be used to indicate the onset of a viral infection, such as COVID-19.Helo Corp's smartwatch data is already being used in an early alert system called Guardian Alert, which is available to VYVO smartwatch wearers who have pre-selected their guardians for notification if their data indicates that they have fallen or they have had an Atrial Fibrillation episode or a sleep apnea event. In addition, the Guardian Alert system notifies guardians if the wearer's breath rate, heart rate, blood oxygenation and temperature are outside of their normal ranges.Although Helo Corp's non-invasive devices are intended only for general wellness use and provide personal tracking as part of promoting a healthy lifestyle, we believe the data that these devices gather will provide useful insights for participants in Project CEASE, both VYVO smartwatch wearers and the health and medical professionals who join us. In addition, Project CEASE data will soon be enhanced with data from VYVO's latest devices which are currently in production and use medical grade sensors for temperature measurement. These sensors provide ± 0.1°C accuracy from 30 to 45°C (86 to 113°F) and meet the American Society for Testing and Materials (ASTM) E1112 and International Organization for Standardization (ISO) 80601 requirements for patient thermometers.Helo Corp is asking VYVO smartwatch wearers to share their ongoing bio-data gathered from their VYVO smartwatch and to complete a health status questionnaire, which will includes results from the rapid antibody COVID-19 test kit that is being provided to wearers that participate in Project CEASE. These test kits with two separate tests included, have already been sourced from approved manufacturers and selected for participants depending on the participant's location, to ensure compliance with their local countr...